Anna Linder
6PUBLICATIONS
152CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey
|Nov 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.Dale Garsed, Tibor Zwimpfer, Sian Fereday
|Mar 09, 2024
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma.A Linder, S Westbom-Fremer, C Mateoiu
|Oct 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.Nicola S Meagher, Kylie L Gorringe, Matthew Wakefield
|Apr 06, 2021
Inhibition of STAT3 prevents bone metastatic progression of prostate cancer in vivo.Malin Hagberg Thulin, Jorma Määttä, Anna Linder
|May 26, 2020
RGS2 is prognostic for development of castration resistance and cancer-specific survival in castration-resistant prostate cancer.Anna Linder, Karin Larsson, Karin Welén
Pageof 1
Frequent Collaborators
3 joint publications
Paul Pharoah
3 joint publications
Beth Y Karlan
3 joint publications
Martin Köbel
3 joint publications
Anna DeFazio
3 joint publications
Peter Fasching
3 joint publications
Anusha Hettiaratchi
3 joint publications
Paul Cohen
3 joint publications
Yee Leung
3 joint publications
James D Brenton
3 joint publications
Michael S Anglesio
